BACKGROUND: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their pathology. Analysis of larger datasets of mutation carriers should allow further tumor characterization. METHODS: We used data from 4,325 BRCA1 and 2,568 BRCA2 mutation carriers to analyze the pathology of invasive breast, ovarian, and contralateral breast cancers. RESULTS: There was strong evidence that the proportion of estrogen receptor (ER)-negative breast tumors decreased with age at diagnosis among BRCA1 (P-trend = 1.2 × 10(-5)), but increased with age at diagnosis among BRCA2, carriers (P-trend = 6.8 × 10(-6)). The proportion of triple-negative tumors decreased with age at diagnosis in BRCA1 carriers but increased with age at diagnosis of BRCA2 carriers. In both BRCA1 and BRCA2 carriers, ER-negative tumors were of higher histologic grade than ER-positive tumors (grade 3 vs. grade 1; P = 1.2 × 10(-13) for BRCA1 and P = 0.001 for BRCA2). ER and progesterone receptor (PR) expression were independently associated with mutation carrier status [ER-positive odds ratio (OR) for BRCA2 = 9.4, 95% CI: 7.0-12.6 and PR-positive OR = 1.7, 95% CI: 1.3-2.3, under joint analysis]. Lobular tumors were more likely to be BRCA2-related (OR for BRCA2 = 3.3, 95% CI: 2.4-4.4; P = 4.4 × 10(-14)), and medullary tumors BRCA1-related (OR for BRCA2 = 0.25, 95% CI: 0.18-0.35; P = 2.3 × 10(-15)). ER-status of the first breast cancer was predictive of ER-status of asynchronous contralateral breast cancer (P = 0.0004 for BRCA1; P = 0.002 for BRCA2). There were no significant differences in ovarian cancer morphology between BRCA1 and BRCA2 carriers (serous: 67%; mucinous: 1%; endometrioid: 12%; clear-cell: 2%). CONCLUSIONS/IMPACT: Pathologic characteristics of BRCA1 and BRCA2 tumors may be useful for improving risk-prediction algorithms and informing clinical strategies for screening and prophylaxis.
BACKGROUND: Previously, small studies have found that BRCA1 and BRCA2breast tumors differ in their pathology. Analysis of larger datasets of mutation carriers should allow further tumor characterization. METHODS: We used data from 4,325 BRCA1 and 2,568 BRCA2 mutation carriers to analyze the pathology of invasive breast, ovarian, and contralateral breast cancers. RESULTS: There was strong evidence that the proportion of estrogen receptor (ER)-negative breast tumors decreased with age at diagnosis among BRCA1 (P-trend = 1.2 × 10(-5)), but increased with age at diagnosis among BRCA2, carriers (P-trend = 6.8 × 10(-6)). The proportion of triple-negative tumors decreased with age at diagnosis in BRCA1 carriers but increased with age at diagnosis of BRCA2 carriers. In both BRCA1 and BRCA2 carriers, ER-negative tumors were of higher histologic grade than ER-positive tumors (grade 3 vs. grade 1; P = 1.2 × 10(-13) for BRCA1 and P = 0.001 for BRCA2). ER and progesterone receptor (PR) expression were independently associated with mutation carrier status [ER-positive odds ratio (OR) for BRCA2 = 9.4, 95% CI: 7.0-12.6 and PR-positive OR = 1.7, 95% CI: 1.3-2.3, under joint analysis]. Lobular tumors were more likely to be BRCA2-related (OR for BRCA2 = 3.3, 95% CI: 2.4-4.4; P = 4.4 × 10(-14)), and medullary tumorsBRCA1-related (OR for BRCA2 = 0.25, 95% CI: 0.18-0.35; P = 2.3 × 10(-15)). ER-status of the first breast cancer was predictive of ER-status of asynchronous contralateral breast cancer (P = 0.0004 for BRCA1; P = 0.002 for BRCA2). There were no significant differences in ovarian cancer morphology between BRCA1 and BRCA2 carriers (serous: 67%; mucinous: 1%; endometrioid: 12%; clear-cell: 2%). CONCLUSIONS/IMPACT: Pathologic characteristics of BRCA1 and BRCA2 tumors may be useful for improving risk-prediction algorithms and informing clinical strategies for screening and prophylaxis.
Authors: J E Armes; L Trute; D White; M C Southey; F Hammet; A Tesoriero; A M Hutchins; G S Dite; M R McCredie; G G Giles; J L Hopper; D J Venter Journal: Cancer Res Date: 1999-04-15 Impact factor: 12.701
Authors: José Palacios; Emiliano Honrado; Ana Osorio; Alicia Cazorla; David Sarrió; Alicia Barroso; Sandra Rodríguez; Juan C Cigudosa; Orland Diez; Carmen Alonso; Enrique Lerma; Joaquín Dopazo; Carmen Rivas; Javier Benítez Journal: Breast Cancer Res Treat Date: 2005-03 Impact factor: 4.872
Authors: Jeffrey N Weitzel; Mark Robson; Barbara Pasini; Siranoush Manoukian; Dominique Stoppa-Lyonnet; Henry T Lynch; Jane McLennan; William D Foulkes; Teresa Wagner; Nadine Tung; Parviz Ghadirian; Olufunmilayo Olopade; Claudine Isaacs; Charmaine Kim-Sing; Pal Møller; Susan L Neuhausen; Kelly Metcalfe; Ping Sun; Steven A Narod Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-06 Impact factor: 4.254
Authors: S R Lakhani; J Jacquemier; J P Sloane; B A Gusterson; T J Anderson; M J van de Vijver; L M Farid; D Venter; A Antoniou; A Storfer-Isser; E Smyth; C M Steel; N Haites; R J Scott; D Goldgar; S Neuhausen; P A Daly; W Ormiston; R McManus; S Scherneck; B A Ponder; D Ford; J Peto; D Stoppa-Lyonnet; Y J Bignon; J P Struewing; N K Spurr; D T Bishop; J G Klijn; P Devilee; C J Cornelisse; C Lasset; G Lenoir; R B Barkardottir; V Egilsson; U Hamann; J Chang-Claude; H Sobol; B Weber; M R Stratton; D F Easton Journal: J Natl Cancer Inst Date: 1998-08-05 Impact factor: 13.506
Authors: J E Armes; A J Egan; M C Southey; G S Dite; M R McCredie; G G Giles; J L Hopper; D J Venter Journal: Cancer Date: 1998-12-01 Impact factor: 6.860
Authors: Sunil R Lakhani; Jorge S Reis-Filho; Laura Fulford; Frederique Penault-Llorca; Marc van der Vijver; Suzanne Parry; Timothy Bishop; Javier Benitez; Carmen Rivas; Yves-Jean Bignon; Jenny Chang-Claude; Ute Hamann; Cees J Cornelisse; Peter Devilee; Matthias W Beckmann; Carolin Nestle-Krämling; Peter A Daly; Neva Haites; Jenny Varley; Fiona Lalloo; Gareth Evans; Christine Maugard; Hanne Meijers-Heijboer; Jan G M Klijn; Edith Olah; Barry A Gusterson; Silvana Pilotti; Paolo Radice; Siegfried Scherneck; Hagay Sobol; Jocelyne Jacquemier; Teresa Wagner; Julian Peto; Michael R Stratton; Lesley McGuffog; Douglas F Easton Journal: Clin Cancer Res Date: 2005-07-15 Impact factor: 12.531
Authors: Hannaleena Eerola; Päivi Heikkilä; Anitta Tamminen; Kristiina Aittomäki; Carl Blomqvist; Heli Nevanlinna Journal: Breast Cancer Res Date: 2005-04-21 Impact factor: 6.466
Authors: Olga Kim; Eun Young Park; Sun Young Kwon; Sojin Shin; Robert E Emerson; Yong-Hyun Shin; Francesco J DeMayo; John P Lydon; Donna M Coffey; Shannon M Hawkins; Lawrence A Quilliam; Dong-Joo Cheon; Facundo M Fernández; Kenneth P Nephew; Adam R Karpf; Martin Widschwendter; Anil K Sood; Robert C Bast; Andrew K Godwin; Kathy D Miller; Chi-Heum Cho; Jaeyeon Kim Journal: Proc Natl Acad Sci U S A Date: 2020-12-01 Impact factor: 11.205
Authors: Joris van de Haar; Sander Canisius; Michael K Yu; Emile E Voest; Lodewyk F A Wessels; Trey Ideker Journal: Cell Date: 2019-05-30 Impact factor: 41.582
Authors: Alison M Dunning; Kyriaki Michailidou; Karoline B Kuchenbaecker; Deborah Thompson; Juliet D French; Jonathan Beesley; Catherine S Healey; Siddhartha Kar; Karen A Pooley; Elena Lopez-Knowles; Ed Dicks; Daniel Barrowdale; Nicholas A Sinnott-Armstrong; Richard C Sallari; Kristine M Hillman; Susanne Kaufmann; Haran Sivakumaran; Mahdi Moradi Marjaneh; Jason S Lee; Margaret Hills; Monika Jarosz; Suzie Drury; Sander Canisius; Manjeet K Bolla; Joe Dennis; Qin Wang; John L Hopper; Melissa C Southey; Annegien Broeks; Marjanka K Schmidt; Artitaya Lophatananon; Kenneth Muir; Matthias W Beckmann; Peter A Fasching; Isabel Dos-Santos-Silva; Julian Peto; Elinor J Sawyer; Ian Tomlinson; Barbara Burwinkel; Frederik Marme; Pascal Guénel; Thérèse Truong; Stig E Bojesen; Henrik Flyger; Anna González-Neira; Jose I A Perez; Hoda Anton-Culver; Lee Eunjung; Volker Arndt; Hermann Brenner; Alfons Meindl; Rita K Schmutzler; Hiltrud Brauch; Ute Hamann; Kristiina Aittomäki; Carl Blomqvist; Hidemi Ito; Keitaro Matsuo; Natasha Bogdanova; Thilo Dörk; Annika Lindblom; Sara Margolin; Veli-Matti Kosma; Arto Mannermaa; Chiu-Chen Tseng; Anna H Wu; Diether Lambrechts; Hans Wildiers; Jenny Chang-Claude; Anja Rudolph; Paolo Peterlongo; Paolo Radice; Janet E Olson; Graham G Giles; Roger L Milne; Christopher A Haiman; Brian E Henderson; Mark S Goldberg; Soo H Teo; Cheng Har Yip; Silje Nord; Anne-Lise Borresen-Dale; Vessela Kristensen; Jirong Long; Wei Zheng; Katri Pylkäs; Robert Winqvist; Irene L Andrulis; Julia A Knight; Peter Devilee; Caroline Seynaeve; Jonine Figueroa; Mark E Sherman; Kamila Czene; Hatef Darabi; Antoinette Hollestelle; Ans M W van den Ouweland; Keith Humphreys; Yu-Tang Gao; Xiao-Ou Shu; Angela Cox; Simon S Cross; William Blot; Qiuyin Cai; Maya Ghoussaini; Barbara J Perkins; Mitul Shah; Ji-Yeob Choi; Daehee Kang; Soo Chin Lee; Mikael Hartman; Maria Kabisch; Diana Torres; Anna Jakubowska; Jan Lubinski; Paul Brennan; Suleeporn Sangrajrang; Christine B Ambrosone; Amanda E Toland; Chen-Yang Shen; Pei-Ei Wu; Nick Orr; Anthony Swerdlow; Lesley McGuffog; Sue Healey; Andrew Lee; Miroslav Kapuscinski; Esther M John; Mary Beth Terry; Mary B Daly; David E Goldgar; Saundra S Buys; Ramunas Janavicius; Laima Tihomirova; Nadine Tung; Cecilia M Dorfling; Elizabeth J van Rensburg; Susan L Neuhausen; Bent Ejlertsen; Thomas V O Hansen; Ana Osorio; Javier Benitez; Rachel Rando; Jeffrey N Weitzel; Bernardo Bonanni; Bernard Peissel; Siranoush Manoukian; Laura Papi; Laura Ottini; Irene Konstantopoulou; Paraskevi Apostolou; Judy Garber; Muhammad Usman Rashid; Debra Frost; Louise Izatt; Steve Ellis; Andrew K Godwin; Norbert Arnold; Dieter Niederacher; Kerstin Rhiem; Nadja Bogdanova-Markov; Charlotte Sagne; Dominique Stoppa-Lyonnet; Francesca Damiola; Olga M Sinilnikova; Sylvie Mazoyer; Claudine Isaacs; Kathleen B M Claes; Kim De Leeneer; Miguel de la Hoya; Trinidad Caldes; Heli Nevanlinna; Sofia Khan; Arjen R Mensenkamp; Maartje J Hooning; Matti A Rookus; Ava Kwong; Edith Olah; Orland Diez; Joan Brunet; Miquel Angel Pujana; Jacek Gronwald; Tomasz Huzarski; Rosa B Barkardottir; Rachel Laframboise; Penny Soucy; Marco Montagna; Simona Agata; Manuel R Teixeira; Sue Kyung Park; Noralane Lindor; Fergus J Couch; Marc Tischkowitz; Lenka Foretova; Joseph Vijai; Kenneth Offit; Christian F Singer; Christine Rappaport; Catherine M Phelan; Mark H Greene; Phuong L Mai; Gad Rennert; Evgeny N Imyanitov; Peter J Hulick; Kelly-Anne Phillips; Marion Piedmonte; Anna Marie Mulligan; Gord Glendon; Anders Bojesen; Mads Thomassen; Maria A Caligo; Sook-Yee Yoon; Eitan Friedman; Yael Laitman; Ake Borg; Anna von Wachenfeldt; Hans Ehrencrona; Johanna Rantala; Olufunmilayo I Olopade; Patricia A Ganz; Robert L Nussbaum; Simon A Gayther; Katherine L Nathanson; Susan M Domchek; Banu K Arun; Gillian Mitchell; Beth Y Karlan; Jenny Lester; Gertraud Maskarinec; Christy Woolcott; Christopher Scott; Jennifer Stone; Carmel Apicella; Rulla Tamimi; Robert Luben; Kay-Tee Khaw; Åslaug Helland; Vilde Haakensen; Mitch Dowsett; Paul D P Pharoah; Jacques Simard; Per Hall; Montserrat García-Closas; Celine Vachon; Georgia Chenevix-Trench; Antonis C Antoniou; Douglas F Easton; Stacey L Edwards Journal: Nat Genet Date: 2016-02-29 Impact factor: 38.330
Authors: Joanne Kotsopoulos; Jan Lubinski; Jacek Gronwald; Cezary Cybulski; Rochelle Demsky; Susan L Neuhausen; Charmaine Kim-Sing; Nadine Tung; Susan Friedman; Leigha Senter; Jeffrey Weitzel; Beth Karlan; Pal Moller; Ping Sun; Steven A Narod Journal: Int J Cancer Date: 2014-12-18 Impact factor: 7.396
Authors: Meghan J Walker; Lucia Mirea; Kristine Cooper; Mitra Nabavi; Gord Glendon; Irene L Andrulis; Julia A Knight; Frances P O'Malley; Anna M Chiarelli Journal: Fam Cancer Date: 2014-06 Impact factor: 2.375